Eubel Brady & Suttman Asset Management’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$640K Buy
8,907
+6,510
+272% +$613K 0.08% 72
2026
Q1
$283K Buy
2,397
+236
+11% +$29.2K 0.03% 97
2025
Q4
$272K Hold
2,161
0.03% 103
2025
Q3
$316K Buy
+2,161
New +$327K 0.04% 94
2021
Q3
Sell
-295
Closed -$46K 360
2021
Q2
$46K Buy
+295
New +$51.2K ﹤0.01% 346

Other funds holding ZTS

Eubel Brady & Suttman Asset Management's ZTS Position: Q2 2026 in Review

Eubel Brady & Suttman Asset Management increased its Zoetis (ZTS) stake by 272% in Q2 2026, buying an estimated $613K and bringing the position to 8,907 shares worth $640K. The position accounts for 0.08% of the portfolio, ranked #72.

Eubel Brady & Suttman Asset Management first reported a position in ZTS in Q2 2021 and has held it in 5 quarters since. 1,430 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Eubel Brady & Suttman Asset Management held 8,907 shares of Zoetis worth $640K as of Q2 2026.
  • Eubel Brady & Suttman Asset Management bought 6,510 Zoetis shares in Q2 2026, an estimated $613K.
  • Zoetis made up 0.08% of Eubel Brady & Suttman Asset Management's portfolio in Q2 2026, its #72 holding.
  • Eubel Brady & Suttman Asset Management first reported a position in Zoetis in Q2 2021 and has held it in 5 quarters since.
  • 1,430 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Eubel Brady & Suttman Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.